Gilead Sciences Inc. Sees Increased Stake from Optas, LLC Amid Q3 Earnings
ByAinvest
Saturday, Feb 7, 2026 11:13 am ET1min read
GILD--
Optas LLC raised its stake in Gilead Sciences Inc (GILD) by 5.54% to 3,775 shares valued at $463,350. Other large investors also modified their holdings of the stock, including Leo Wealth, Signature Resources Capital Management, Allen Mooney & Barnes Investment Advisors, Sowell Financial Services LLC, and Revolve Wealth Partners. GILD's price performance includes a 52-week low of $93.37 and a 52-week high of $150.50, with a market capitalization of $185.32 billion.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet